Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2017, Article ID 9538920, 4 pages
https://doi.org/10.1155/2017/9538920
Case Report

Successful Long-Term Use of Eltrombopag in a Patient with Refractory Severe Thrombocytopenia Associated with Chronic Lymphocytic Leukemia That Allowed Oral Anticoagulant Treatment for Severe Cardiomyopathy

Division of Hematology, Principe de Asturias University Hospital, Madrid, Spain

Correspondence should be addressed to Juárez Salcedo Luis Miguel; moc.liamg@zeraujsiul.rd

Received 4 January 2017; Revised 12 February 2017; Accepted 19 March 2017; Published 2 April 2017

Academic Editor: Massimo Gentile

Copyright © 2017 Juárez Salcedo Luis Miguel and Gil-Fernández Juan José. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Autoimmune cytopenias (AICs) are frequently associated with chronic lymphocytic leukemia (CLL). The most common of these AICs is autoimmune hemolytic anemia (AIHA); the second most is immune thrombocytopenia (ITP). Here, we report on a patient with CLL-associated ITP, with thrombocytopenia refractory to corticosteroids and intravenous immunoglobulins, in which continuous oral treatment with Eltrombopag allowed initiation and maintenance of an oral anticoagulation treatment with Acenocoumarol that was indicated because of a severe arrhythmogenic cardiomyopathy.